Dmitry Balyasny’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$601K Buy
+2,700
New +$628K ﹤0.01% 2473
2022
Q4
– Sell
-10,000
Closed -$667K – 2809
2022
Q3
$667K Buy
+10,000
New +$634K ﹤0.01% 1951
2018
Q4
– Sell
-80,000
Closed -$4.32M – 1426
2018
Q3
$4.32M Buy
+80,000
New +$4.09M 0.02% 754
2018
Q1
– Sell
-350,000
Closed -$21.4M – 1965
2017
Q4
$21.4M Buy
+350,000
New +$21.6M 0.07% 377
2017
Q1
– Sell
-113,300
Closed -$8.15M – 1598
2016
Q4
$8.15M Buy
+113,300
New +$8.19M 0.04% 543

Other funds holding CAH

Dmitry Balyasny's CAH Position: Q3 2026 in Review

Dmitry Balyasny increased its Cardinal Health (CAH) stake by 44% in Q3 2026, buying an estimated $14.1M and bringing the position to 199,395 shares worth $44.4M. The position accounts for 0.05% of the portfolio, ranked #425.

Dmitry Balyasny first reported a position in CAH in Q2 2013 and has held it in 39 quarters since. The position peaked at $110M in Q1 2025. 1,497 funds tracked by Wall St. Rank hold CAH as of Q3 2026.

  • Dmitry Balyasny held 199,395 shares of Cardinal Health worth $44.4M as of Q3 2026.
  • Dmitry Balyasny bought 60,807 Cardinal Health shares in Q3 2026, an estimated $14.1M.
  • Cardinal Health made up 0.05% of Dmitry Balyasny's portfolio in Q3 2026, its #425 holding.
  • Dmitry Balyasny first reported a position in Cardinal Health in Q2 2013 and has held it in 39 quarters since.
  • Dmitry Balyasny's Cardinal Health position peaked at $110M in Q1 2025.
  • 1,497 funds tracked by Wall St. Rank held Cardinal Health as of Q3 2026.

Based on Balyasny Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.